These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25708172)

  • 1. Innate and adaptive genetic pathways in HCV infection.
    Buchanan R; Hydes T; Khakoo SI
    Tissue Antigens; 2015 Apr; 85(4):231-40. PubMed ID: 25708172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.
    O'Connor KS; George J; Booth D; Ahlenstiel G
    World J Gastroenterol; 2014 Dec; 20(47):17830-8. PubMed ID: 25548481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and adaptive immunity shape circulating HCV strains.
    Gaudieri S; Lucas M
    Nat Genet; 2017 Apr; 49(5):657-658. PubMed ID: 28442794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of hepatic innate immunity by hepatitis C virus.
    Horner SM; Gale M
    Nat Med; 2013 Jul; 19(7):879-88. PubMed ID: 23836238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ system view of the hepatic innate immunity in HCV infection.
    Bang BR; Elmasry S; Saito T
    J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.
    Bruening J; Weigel B; Gerold G
    J Immunol Res; 2017; 2017():7232361. PubMed ID: 28255563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis.
    O'Connor KS; Ahlenstiel G; Suppiah V; Schibeci S; Ong A; Leung R; van der Poorten D; Douglas MW; Weltman MD; Stewart GJ; Liddle C; George J; Booth DR
    Innate Immun; 2014 Aug; 20(6):598-605. PubMed ID: 24045339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity and HCV.
    Heim MH
    J Hepatol; 2013 Mar; 58(3):564-74. PubMed ID: 23063572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL28B polymorphisms as a pretreatment predictor of response to HCV treatment.
    Berger CT; Kim AY
    Infect Dis Clin North Am; 2012 Dec; 26(4):863-77. PubMed ID: 23083820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response.
    Asahina Y; Tsuchiya K; Muraoka M; Tanaka K; Suzuki Y; Tamaki N; Hoshioka Y; Yasui Y; Katoh T; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Enomoto N; Nitta S; Sakamoto N; Izumi N
    Hepatology; 2012 Jan; 55(1):20-9. PubMed ID: 21898478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection.
    Lloyd AR; Jagger E; Post JJ; Crooks LA; Rawlinson WD; Hahn YS; Ffrench RA
    Immunol Cell Biol; 2007 Jan; 85(1):24-32. PubMed ID: 17130897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.
    Sheahan T; Imanaka N; Marukian S; Dorner M; Liu P; Ploss A; Rice CM
    Cell Host Microbe; 2014 Feb; 15(2):190-202. PubMed ID: 24528865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity against hepatitis C virus.
    Xu Y; Zhong J
    Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunometabolic Effect of Cholesterol in Hepatitis C Infection: Implications in Clinical Management and Antiviral Therapy.
    González-Aldaco K; Torres-Reyes LA; Ojeda-Granados C; José-Ábrego A; Fierro NA; Román S
    Ann Hepatol; 2018 Oct; 17(6):908-919. PubMed ID: 30600305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection.
    Thimme R; Binder M; Bartenschlager R
    FEMS Microbiol Rev; 2012 May; 36(3):663-83. PubMed ID: 22142141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and evasion of antiviral innate immunity by hepatitis C virus.
    Horner SM
    J Mol Biol; 2014 Mar; 426(6):1198-209. PubMed ID: 24184198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host - hepatitis C viral interactions: The role of genetics.
    Heim MH; Bochud PY; George J
    J Hepatol; 2016 Oct; 65(1 Suppl):S22-S32. PubMed ID: 27641986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current progress in host innate and adaptive immunity against hepatitis C virus infection.
    Shi J; Li Y; Chang W; Zhang X; Wang FS
    Hepatol Int; 2017 Jul; 11(4):374-383. PubMed ID: 28643186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.